Shareholders of Israeli technology firm Elbit last week approvedthe Haifa company's acquisition of the Elscintec ultrasound businessof Elscint, an Elbit subsidiary. Elbit proposed the acquisitionlate last year (SCAN 12/27/95). Elbit continues to study a
Shareholders of Israeli technology firm Elbit last week approved
the Haifa company's acquisition of the Elscintec ultrasound business
of Elscint, an Elbit subsidiary. Elbit proposed the acquisition
late last year (SCAN 12/27/95). Elbit continues to study a plan
to spin off Elbit into three separate firms, including one that
would consolidate the healthcare operations of Elbit and Elscint.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
2 Commerce Drive
Cranbury, NJ 08512